Fujian Wanchen Biotechnology GroupLtd (300972) Stock Overview
Fujian Wanchen Biotechnology Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
300972 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Fujian Wanchen Biotechnology Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥178.52 |
| 52 Week High | CN¥214.93 |
| 52 Week Low | CN¥70.02 |
| Beta | -0.083 |
| 1 Month Change | 2.06% |
| 3 Month Change | -15.71% |
| 1 Year Change | 139.14% |
| 3 Year Change | 1,324.74% |
| 5 Year Change | n/a |
| Change since IPO | 553.92% |
Recent News & Updates
Recent updates
Fujian Wanchen Biotechnology Group (SZSE:300972) Could Become A Multi-Bagger
Feb 24
The Market Lifts Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Shares 26% But It Can Do More
Jan 17Fujian Wanchen Biotechnology Group (SZSE:300972) Seems To Use Debt Quite Sensibly
Dec 26Fujian Wanchen Biotechnology Group's (SZSE:300972) Strong Earnings Are Of Good Quality
Nov 04Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company
Oct 01Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing
Sep 30We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Is Taking Some Risk With Its Debt
Aug 04Sentiment Still Eluding Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972)
Jun 06Shareholder Returns
| 300972 | CN Food | CN Market | |
|---|---|---|---|
| 7D | 7.1% | 1.2% | 2.8% |
| 1Y | 139.1% | 4.7% | 18.3% |
Return vs Industry: 300972 exceeded the CN Food industry which returned 4.7% over the past year.
Return vs Market: 300972 exceeded the CN Market which returned 18.3% over the past year.
Price Volatility
| 300972 volatility | |
|---|---|
| 300972 Average Weekly Movement | 6.7% |
| Food Industry Average Movement | 4.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 9.3% |
| 10% least volatile stocks in CN Market | 3.1% |
Stable Share Price: 300972 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300972's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 7,904 | Li Qing Wang | www.vanchen.com |
Fujian Wanchen Biotechnology Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. The company offers enoki and golden enoki, white jade, crab, seafood, deer antler, oyster, and other mushrooms products, as well as flammulina velutipes, hydrangea edulis, and pleurotus eryngii. It is also involved in breeding and fruit testing to produce new variants of edible fungi.
Fujian Wanchen Biotechnology Group Co.,Ltd. Fundamentals Summary
| 300972 fundamental statistics | |
|---|---|
| Market cap | CN¥33.72b |
| Earnings (TTM) | CN¥1.06b |
| Revenue (TTM) | CN¥48.28b |
Is 300972 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300972 income statement (TTM) | |
|---|---|
| Revenue | CN¥48.28b |
| Cost of Revenue | CN¥42.69b |
| Gross Profit | CN¥5.58b |
| Other Expenses | CN¥4.52b |
| Earnings | CN¥1.06b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.64 |
| Gross Margin | 11.57% |
| Net Profit Margin | 2.20% |
| Debt/Equity Ratio | 40.4% |
How did 300972 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/29 03:19 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fujian Wanchen Biotechnology Group Co.,Ltd. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wendan Wang | China International Capital Corporation Limited |
| Yuanyuan Kou | Haitong International Research Limited |
| Katharine Song | HSBC |